LIFECORE BIOMEDICAL, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
LIFECORE BIOMEDICAL, INC. (LFCR) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of -420.13 thousand shares for the 12-month period ending 2014-05-25, per its 10-K filed 2014-08-01.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2014-08-01
- LIFECORE BIOMEDICAL, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2014 was -420.13K shares.
- LIFECORE BIOMEDICAL, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2013 was -26.67K shares.
- LIFECORE BIOMEDICAL, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2012 was -191.33K shares, a 247.94% decline from fiscal 2011.
- LIFECORE BIOMEDICAL, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2011 was 129.34K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month as first filed |
|---|---|---|
| 2014-05-25 | -420.13K shares 10-K · filed 2014-08-01 | |
| 2013-05-26 | -26.67K shares 10-K · filed 2014-08-01 | 26.67K shares 10-K · filed 2013-08-07 |
| 2012-05-27 | -191.33K shares 10-K · filed 2014-08-01 | 191.33K shares 10-K · filed 2013-08-07 |
| 2011-05-29 | 129.34K shares 10-K · filed 2013-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |